• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

    4/4/24 9:05:00 AM ET
    $ATEC
    $SYK
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ATEC alert in real time by email

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years.

    "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new territories, and establishing customer relationships. His experience and level of commitment bring an added degree of sophistication to our selling process. I have full confidence that he will continue to build an incredible sales team that compels surgeons, distributors, and the market to leverage Spineology technology," added Snider.

    Emory Rooney is joining Spineology with nearly two decades of medical device experience. Prior to joining Spineology, Mr. Rooney spent nearly six years with Alphatec Spine (NASDAQ:ATEC), where he served as the Vice President of Sales, East. Under his leadership his territory grew by ten times, achieving over $100 million in annual sales during his tenure. Prior to his time at ATEC, Mr. Rooney had a successful ten-year career with Stryker (NASDAQ:SYK), beginning with various sales representative roles at Stryker Navigation and Stryker Spine, and advancing into numerous leadership roles as a Branch manager, Regional Sales Manager and Area Vice President. Mr. Rooney also proudly serves as a board member for the International Spine Foundation, a non-profit that serves underprivileged spine patients in need of care. Mr. Rooney received his bachelor's degree in political science from the University of Central Florida.

    "The opportunity to join this growing team of spine experts compelled me to the Spineology organization," said Rooney. "After learning more about the versatility of the Optimesh® technology, and the incredible hospital access garnered by the uniqueness of the implant, one that is supported by IDE level data, it was an easy decision to jump on board. I am thrilled to join an organization that I know is set up for exceptional growth."

    With Mr. Rooney's hire, Spineology furthers its continued organizational expansion across the United States, with a core focus on its OptiMesh portfolio of implants.

    About Spineology

    Spineology Inc. leads the way in ultra-minimally invasive spine surgery, revolutionizing how surgeons treat patients with spinal pathologies. Its proprietary technology, OptiMesh sets the company apart from traditional fusion procedures enabling surgeons to optimize outcomes, while minimizing tissue disruption and enhancing patient recovery. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240404165010/en/

    Get the next $ATEC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEC
    $SYK

    CompanyDatePrice TargetRatingAnalyst
    Alphatec Holdings Inc.
    $ATEC
    10/28/2025$20.00Buy
    Stifel
    Alphatec Holdings Inc.
    $ATEC
    10/24/2025$19.00Overweight
    Analyst
    Stryker Corporation
    $SYK
    9/18/2025$420.00Neutral
    Rothschild & Co Redburn
    Alphatec Holdings Inc.
    $ATEC
    6/16/2025$18.00Buy
    Lake Street
    Stryker Corporation
    $SYK
    2/26/2025$450.00Buy
    Citigroup
    Stryker Corporation
    $SYK
    12/2/2024$370.00 → $445.00Equal-Weight → Overweight
    Morgan Stanley
    Stryker Corporation
    $SYK
    9/10/2024$405.00Outperform
    Wolfe Research
    Alphatec Holdings Inc.
    $ATEC
    8/1/2024Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ATEC
    $SYK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:32:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:27:25 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Demski David M bought $283,500 worth of shares (50,000 units at $5.67), increasing direct ownership by 21% to 288,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/21/24 10:00:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance

    Total revenue grew $46 million or 30% to $197 million Surgical revenue grew 31% to $177 million Full-year revenue and profitability guidance increased Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2025, and recent corporate highlights. Third Quarter 2025 Financial Results   Quarter Ended September 30, 2025 Total revenue $197 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $153 million Non-GAAP operating ex

    10/30/25 4:05:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Stryker reports third quarter 2025 operating results

    Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1) increased 90 bps to 25.6%Reported EPS increased 2.8% to $2.22Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        14.4        %         0.5        %         13.9        %         5.5        %         8.4        %Orthopaedics        3

    10/30/25 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel resumed coverage on Alphatec with a new price target

    Stifel resumed coverage of Alphatec with a rating of Buy and set a new price target of $20.00

    10/28/25 7:09:19 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Analyst initiated coverage on Alphatec with a new price target

    Analyst initiated coverage of Alphatec with a rating of Overweight and set a new price target of $19.00

    10/24/25 8:59:42 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Rothschild & Co Redburn initiated coverage on Stryker with a new price target

    Rothschild & Co Redburn initiated coverage of Stryker with a rating of Neutral and set a new price target of $420.00

    9/18/25 8:44:39 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stryker Ronda E sold $184,606,141 worth of shares (520,000 units at $355.01) (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    11/7/25 4:22:08 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Director Rydin Jeffrey P sold $3,864,000 worth of shares (200,000 units at $19.32), decreasing direct ownership by 34% to 385,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    11/5/25 6:30:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CEO Miles Patrick sold $1,896,000 worth of shares (100,000 units at $18.96), decreasing direct ownership by 2% to 5,364,078 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    11/5/25 6:30:05 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    SEC Filings

    View All

    Alphatec Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    11/7/25 9:10:27 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Alphatec Holdings Inc.

    144 - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/4/25 4:29:53 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Stryker Corporation

    10-Q - STRYKER CORP (0000310764) (Filer)

    10/31/25 10:39:02 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    3/11/25 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Kadant Set to Join S&P SmallCap 600

    NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE:KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE:SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name      Action Company Name Ticker GICS Sector February 19, 2025 S&P SmallCap 600 Addition Kadant KAI Industrials February 19, 2025 S&P SmallCap 600 Deletion Inari Medical NARI Health Care For more information about

    2/13/25 5:54:00 PM ET
    $KAI
    $NARI
    $SPGI
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Financials

    Live finance-specific insights

    View All

    Stryker reports third quarter 2025 operating results

    Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1) increased 90 bps to 25.6%Reported EPS increased 2.8% to $2.22Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        14.4        %         0.5        %         13.9        %         5.5        %         8.4        %Orthopaedics        3

    10/30/25 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations section of ATEC's corporate website. Dial-In To dial into the live webcast, please register at this link. Access details will be provided via email. Replay A replay of the webcast will remain available through the Investor Relations section of ATEC's corporate website for twelve month

    10/16/25 4:10:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Stryker declares an $0.84 per share quarterly dividend

    Portage, Michigan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable October 31, 2025, to shareholders of record at the close of business on September 30, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more

    8/7/25 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/12/24 8:04:57 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    3/22/24 7:57:56 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care